Inflammatory Pathways in Osteoarthritis Treatment

Osteoarthritis is characterised by progressive cartilage degeneration and joint pain, in which chronic inflammation plays a central role. Molecular signalling cascades involving key cytokines—particularly interleukin-1β (IL-1β) and tumour necrosis factor α (TNF-α)—activate intracellular pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinases (MAPKs) and the phosphoinositide 3-kinase/Akt (PI3K/Akt) axis. These pathways drive the expression of matrix metalloproteinases (MMPs) and aggrecanases (ADAMTS), leading to extracellular matrix breakdown and chondrocyte apoptosis. Contemporary therapeutic strategies aim to modulate these pathways by using small-molecule inhibitors, biologics, natural products and cell-derived therapies. Advances in nanoparticle delivery and exosome-mediated targeting have further enhanced the precision of anti-inflammatory interventions. Globally, such approaches promise not only symptom relief but also disease-modifying effects, bridging the gap between symptom management and cartilage preservation. Practical applications range from dietary flavonoids as NF-κB modulators to mesenchymal stem-cell exosomes attenuating inflammatory cytokine production, reflecting a multifaceted strategy to arrest osteoarthritic progression.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Inflammatory Pathways in Osteoarthritis Treatment publication trend

The graph below shows the total number of articles in inflammatory pathways in osteoarthritis treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Interleukin-1β (IL-1β): A pro-inflammatory cytokine that initiates signalling cascades leading to cartilage degradation in osteoarthritis.

Nuclear factor-κB (NF-κB): A transcription factor that regulates genes encoding pro-inflammatory cytokines, MMPs and adhesion molecules.

Mitogen-activated protein kinases (MAPKs): A family of kinases (ERK, JNK, p38) that transduce extracellular stress signals into inflammatory gene expression.

PI3K/Akt pathway: An intracellular signalling cascade involved in cell survival and inflammation; its dysregulation contributes to osteoarthritic pathology.

Exosomes: Nano-sized vesicles secreted by cells, carrying proteins and RNAs that can modulate recipient cell function and inflammation.

References

1. Cucurbitacin E reduces IL-1β-induced inflammation and cartilage degeneration by inhibiting the PI3K/Akt pathway in osteoarthritic chondrocytes. Journal of Translational Medicine (2023).
2. Effects of human umbilical cord mesenchymal stem cell-derived exosomes in the rat osteoarthritis models. Stem Cells Translational Medicine (2024).
3. Urolithin a attenuates IL-1β-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-κB signaling pathways in rat articular chondrocytes. Journal of Inflammation (2020).
4. The protective activity of natural flavonoids against osteoarthritis by targeting NF-κB signaling pathway. Frontiers in Endocrinology (2023).